FEDERATED HERMES, INC. - VOYAGER THERAPEUTICS INC ownership

VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 121 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,525,109
-32.8%
583,885
-0.7%
0.01%
-29.4%
Q2 2023$6,735,898
+44.3%
588,288
-2.9%
0.02%
+41.7%
Q1 2023$4,669,315
+26.4%
605,618
-0.0%
0.01%
+20.0%
Q4 2022$3,694,520
+3.0%
605,659
-0.0%
0.01%
-9.1%
Q3 2022$3,586,000
-1.0%
605,795
-1.2%
0.01%
+10.0%
Q2 2022$3,623,000
-23.9%
613,047
-1.9%
0.01%
-9.1%
Q1 2022$4,763,000
+181.0%
625,081
-0.0%
0.01%
+266.7%
Q4 2021$1,695,000
-10.4%
625,340
-13.1%
0.00%
-25.0%
Q3 2021$1,892,000
-32.5%
719,448
+6.1%
0.00%
-20.0%
Q2 2021$2,801,000
+117.5%
678,325
+148.1%
0.01%
+150.0%
Q1 2021$1,288,000
-41.7%
273,432
-11.6%
0.00%
-60.0%
Q4 2020$2,211,000
-33.0%
309,163
-0.1%
0.01%
-37.5%
Q3 2020$3,301,000
+0.6%
309,378
+19.0%
0.01%0.0%
Q2 2020$3,280,000
-25.0%
259,943
-45.6%
0.01%
-38.5%
Q1 2020$4,372,000
-69.4%
477,858
-53.4%
0.01%
-59.4%
Q4 2019$14,310,000
+12.1%
1,025,822
+38.3%
0.03%
+3.2%
Q3 2019$12,766,000
-7.6%
741,800
+46.1%
0.03%
-8.8%
Q2 2019$13,822,000
+172675.0%
507,778
+124051.1%
0.03%
Q1 2019$8,000
-77.1%
409
-89.0%
0.00%
Q4 2018$35,000
+288.9%
3,733
+695.9%
0.00%
Q3 2018$9,000
-18.2%
469
-13.8%
0.00%
Q2 2018$11,000
-26.7%
544
-33.3%
0.00%
Q1 2018$15,000
-53.1%
816
-57.0%
0.00%
Q4 2017$32,0001,8980.00%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TRV GP III, LLC 7,891,176$154,194,00051.35%
Trustees of Princeton University 203,638$3,979,0004.13%
Casdin Capital, LLC 1,135,000$22,178,0003.10%
GREAT POINT PARTNERS LLC 730,010$14,264,0001.98%
BB BIOTECH AG 2,532,641$49,488,0001.43%
Aevitas Wealth Management, Inc. 73,323$1,433,0001.40%
Patriot Financial Group Insurance Agency, LLC 64,256$1,256,0001.34%
Virtus ETF Advisers LLC 37,502$733,0000.65%
Eventide Asset Management 703,425$13,745,0000.57%
THOMPSON DAVIS & CO., INC. 11,951$234,0000.56%
View complete list of VOYAGER THERAPEUTICS INC shareholders